You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
9 January 2014
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europe and Japan
5 December 2013
Phase III Familial Adenomatous Polyposis (FAP) Trial Now Open for Enrollment
24 August 2011
Cancer Prevention Pharmaceuticals Announces Completion of Bridge Financing Round
29 July 2011
Cancer Prevention Pharmaceuticals Receives Positive Scientific Advice From EMA for CPP-1X Phase III TRIAL in FAP